Uploads
Contact
/
Login
Upload
Search Results for 'Guidance For Industry Considerations'
J:\!GUIDANC\5541fnlcln1.doc 07/06/05
sherrill-nordquist
OECD Guidance
danika-pritchard
Contains Nonbinding Recommendations 1 &#x/MCI; 0 ;&#x/MCI;
myesha-ticknor
Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Pro
phoebe-click
North American Panel
faustina-dinatale
Guidance for Industry Dioxin in AntiCaking Agents Use
trish-goza
Guidance for Industry Regulatory Classification of Pha
debby-jeon
Guidance for Industry
myesha-ticknor
Contains Nonbinding Recommendations &#x/MCI; 1 ;&#x/MCI; 1 ;&#
lindy-dunigan
Guidance for Industry Providing Regulatory Submissions in Electronic
giovanna-bartolotta
Guidance for Industry QD Bracketing and Matrixing Desi
giovanna-bartolotta
Guidance for Industry and Review Staff
ellena-manuel
Guidance for Industry Orally Disintegrating Tablets U
yoshiko-marsland
Guidance for Industry Initial Completeness Assessment
debby-jeon
Guidance for Industry Pyrogen and Endotoxins Testing Q
danika-pritchard
Guidance for Industry Collection of Race and Ethnicity
natalia-silvester
JGuidancdft Guidance for Industry Public Availability
lois-ondreau
Guidance for Industry Q3B(R2) Impurities in New Drug Products
myesha-ticknor
Guidance for Industry
faustina-dinatale
Guidance for Industry Bioanalytical Method Validation U
trish-goza
&#x/MCI; 29; &#x/MCI; 29; Patient Preference Information
mitsue-stanley
Guidance for Industry ConsumerDirected Broadcast Advertisements U
trish-goza
Guidance for Industry Assay Development for Immunogeni
lindy-dunigan
Guidance for Industry NonPenicillin BetaLactam Drugs A
marina-yarberry
1
2
3
4
5
6
7
8
